(BMI) Badger Meter - Ratings and Ratios
Flow Meters, Valves, Sensors, Software, Instrumentation
BMI EPS (Earnings per Share)
BMI Revenue
Description: BMI Badger Meter
Badger Meter Inc (NYSE:BMI) is a leading manufacturer and marketer of flow measurement, quality control, and communication solutions worldwide, serving water utilities, commercial, and industrial industries. The companys product portfolio includes utility water smart metering solutions, flow instrumentation products, and software technologies, such as BEACON, a secure cloud-hosted software suite that provides alerts and consumer engagement tools.
From a business perspective, Badger Meters revenue streams are diversified across various markets, including water/wastewater, heating, ventilating, and air conditioning, and corporate sustainability. The companys products are sold directly, as well as through resellers and representatives, providing a robust distribution network. Key performance indicators (KPIs) to watch include revenue growth, gross margin expansion, and customer acquisition rates. With a strong presence in the water utility market, Badger Meter is well-positioned to capitalize on the growing demand for smart water management solutions.
Analyzing the companys financials, we can observe a market capitalization of $7.22 billion, indicating a significant presence in the electronic equipment and instruments sub-industry. The price-to-earnings ratio (P/E) of 54.04 and forward P/E of 52.36 suggest that the market has high expectations for the companys future earnings growth. Return on Equity (RoE) of 19.56% is a positive indicator of the companys ability to generate profits from shareholder equity. Other key metrics to monitor include the companys debt-to-equity ratio, interest coverage, and operating cash flow margin.
From a valuation perspective, its essential to consider Badger Meters growth prospects, competitive positioning, and industry trends. The companys focus on innovation, customer engagement, and strategic partnerships will be crucial in driving long-term success. As a Trading Analyst, its essential to continue monitoring the companys performance, industry developments, and market sentiment to identify potential trading opportunities.
BMI Stock Overview
| Market Cap in USD | 5,496m |
| Sub-Industry | Electronic Equipment & Instruments |
| IPO / Inception | 1984-09-07 |
BMI Stock Ratings
| Growth Rating | 52.0% |
| Fundamental | 84.1% |
| Dividend Rating | 62.6% |
| Return 12m vs S&P 500 | -22.9% |
| Analyst Rating | 3.67 of 5 |
BMI Dividends
| Dividend Yield 12m | 0.72% |
| Yield on Cost 5y | 2.39% |
| Annual Growth 5y | 11.75% |
| Payout Consistency | 97.1% |
| Payout Ratio | 30.9% |
BMI Growth Ratios
| Growth Correlation 3m | -90.1% |
| Growth Correlation 12m | 1.2% |
| Growth Correlation 5y | 91.6% |
| CAGR 5y | 25.31% |
| CAGR/Max DD 5y | 0.76 |
| Sharpe Ratio 12m | 0.06 |
| Alpha | -29.52 |
| Beta | 1.222 |
| Volatility | 30.65% |
| Current Volume | 413k |
| Average Volume 20d | 304.9k |
| Stop Loss | 177.4 (-3%) |
| Signal | -2.13 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (135.7m TTM) > 0 and > 6% of Revenue (6% = 52.4m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 2.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 35.42% (prev 47.48%; Δ -12.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 174.8m > Net Income 135.7m (YES >=105%, WARN >=100%) |
| Net Debt (-165.2m) to EBITDA (160.9m) ratio: -1.03 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.6m) change vs 12m ago 0.16% (target <= -2.0% for YES) |
| Gross Margin 41.18% (prev 39.25%; Δ 1.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 101.8% (prev 100.0%; Δ 1.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 7.91
| (A) 0.33 = (Total Current Assets 448.3m - Total Current Liabilities 138.7m) / Total Assets 936.4m |
| (B) 0.64 = Retained Earnings (Balance) 600.8m / Total Assets 936.4m |
| (C) 0.16 = EBIT TTM 135.8m / Avg Total Assets 858.8m |
| (D) 2.46 = Book Value of Equity 638.0m / Total Liabilities 258.8m |
| Total Rating: 7.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.11
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 3.08% = 1.54 |
| 3. FCF Margin 18.77% = 4.69 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC 16.20% = 12.50 |
| 7. RoE 21.57% = 1.80 |
| 8. Rev. Trend 96.55% = 4.83 |
| 9. Rev. CAGR 18.87% = 2.36 |
| 10. EPS Trend 95.69% = 2.39 |
| 11. EPS CAGR 26.66% = 2.50 |
What is the price of BMI shares?
Over the past week, the price has changed by -3.37%, over one month by -2.49%, over three months by -26.22% and over the past year by -9.82%.
Is Badger Meter a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BMI is around 177.10 USD . This means that BMI is currently overvalued and has a potential downside of -3.18%.
Is BMI a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 238.7 | 30.5% |
| Analysts Target Price | 238.7 | 30.5% |
| ValueRay Target Price | 201 | 9.9% |
Last update: 2025-08-30 04:34
BMI Fundamental Data Overview
CCE Cash And Equivalents = 165.2m USD (last quarter)
P/E Trailing = 40.6296
P/E Forward = 40.0
P/S = 6.2884
P/B = 8.1105
P/EG = 2.29
Beta = 0.836
Revenue TTM = 873.9m USD
EBIT TTM = 135.8m USD
EBITDA TTM = 160.9m USD
Long Term Debt = unknown (0.0)
Short Term Debt = unknown (0.0)
Debt = unknown
Net Debt = -165.2m USD (from netDebt column, last quarter)
Enterprise Value = 5.33b USD (5.50b + (null Debt) - CCE 165.2m)
Interest Coverage Ratio = unknown (Ebit TTM 135.8m / Interest Expense TTM 0.0)
FCF Yield = 3.08% (FCF TTM 164.0m / Enterprise Value 5.33b)
FCF Margin = 18.77% (FCF TTM 164.0m / Revenue TTM 873.9m)
Net Margin = 15.53% (Net Income TTM 135.7m / Revenue TTM 873.9m)
Gross Margin = 41.18% ((Revenue TTM 873.9m - Cost of Revenue TTM 514.0m) / Revenue TTM)
Tobins Q-Ratio = 8.36 (Enterprise Value 5.33b / Book Value Of Equity 638.0m)
Interest Expense / Debt = unknown (Interest Expense 205.0k / Debt none)
Taxrate = 24.96% (from yearly Income Tax Expense: 41.6m / 166.5m)
NOPAT = 101.9m (EBIT 135.8m * (1 - 24.96%))
Current Ratio = 3.23 (Total Current Assets 448.3m / Total Current Liabilities 138.7m)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt -165.2m / EBITDA 160.9m)
Debt / FCF = none (Debt none / FCF TTM 164.0m)
Total Stockholder Equity = 629.2m (last 4 quarters mean)
RoA = 14.50% (Net Income 135.7m, Total Assets 936.4m )
RoE = 21.57% (Net Income TTM 135.7m / Total Stockholder Equity 629.2m)
RoCE = 21.59% (Ebit 135.8m / (Equity 629.2m + L.T.Debt 0.0))
RoIC = 16.20% (NOPAT 101.9m / Invested Capital 629.2m)
WACC = unknown (E(5.50b)/V(0.0) * Re(10.52%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(0.25)))
Shares Correlation 5-Years: 70.0 | Cagr: 0.18%
Discount Rate = 10.52% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 73.82% ; FCFE base≈145.3m ; Y1≈179.2m ; Y5≈305.8m
Fair Price DCF = 116.8 (DCF Value 3.44b / Shares Outstanding 29.5m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 96.55 | Revenue CAGR: 18.87%
Rev Growth-of-Growth: -8.36
EPS Correlation: 95.69 | EPS CAGR: 26.66%
EPS Growth-of-Growth: -15.56
Additional Sources for BMI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle